Core Viewpoint - Zhejiang Qiangnao Technology Co., Ltd. has reportedly submitted a confidential IPO application to the Hong Kong Stock Exchange, with CICC and UBS as joint sponsors, indicating a significant move towards public listing in the rapidly growing brain-computer interface (BCI) sector [1][3]. Company Overview - Founded in February 2015, Qiangnao Technology focuses on the development of non-invasive brain-computer interface technology, with products spanning smart bionics, health, and education [1]. - The company has launched several products, including a smart bionic hand, a brain-machine intelligent sleep device, and an attention training system [1]. Financing History - Qiangnao Technology completed a significant financing round in early January, raising approximately 2 billion RMB, marking it as the second-largest financing in the BCI field globally, after Neuralink [3]. - Since its inception, the company has completed six rounds of financing, including a notable $400 million Series A round in 2019 [3][4]. - The latest financing rounds include a $30 million Pre-B round and a $20 million Series B round in 2025 [4]. Market Trends - The BCI sector is experiencing rapid growth, with 26 financing events in 2025 totaling 1.778 billion RMB, a significant increase from 2024 [5]. - The global BCI market is projected to grow from approximately $2.6 billion in 2024 to $2.9 billion in 2025, with a further increase to $3.3 billion by 2026 [5]. - In China, the BCI market is expected to reach 3.8 billion RMB in 2025, up from 3.2 billion RMB in 2024 [5]. Policy Support - The Chinese government is actively promoting the BCI industry, with policies aimed at fostering innovation and establishing industry clusters by 2027 and 2030 [7]. - The national strategy includes BCI as a key area for economic growth, alongside other advanced technologies [7]. Industry Outlook - Analysts predict that the BCI industry is on the verge of significant growth, driven by commercial advancements and policy support [8]. - The transition from laboratory research to commercialization is expected to accelerate, particularly with the anticipated production scale-up by Neuralink [8].

YupDogeDesigner (@cb_doge):Neuralink patients are literally playing games just by thinking.No controllers. Just the mind.We are living in the future and it’s kind of amazing. https://t.co/EPVzxz73w4 ...

全球脑机接口玩家奋楫争先，产业化落地谱写投资蓝图 20260128 摘要 创新药领域，减肥、小核酸及 2L 疗法值得关注。减肥和 IO 赛道市场规 模达千亿美元级别，具弹性机会。小核酸赛道也因高景气度备受关注。 全年维度来看，医药板块值得重点关注。 脑机接口商业化处于起步阶段，是 2026 年投资主线。植入式临床进展 迅速，心伟医疗、爱鹏医疗和乐普医疗安全性具优势。非侵入式方面， 翔宇、迈兰德、创新医疗和诚益通等公司靠前。 政策支持对脑机接口行业发展起到重要引领作用，2025 年推出发展目 标与产业规划蓝图，确立收费项目立项，提高公立医院购买积极性，为 未来纳入医保铺平道路。 脑机接口产业链核心技术壁垒集中于中上游，包括硬件（电极、芯片）、 手术机器人及算法处理等。国产替代进程加速，美好医疗率先卡位上游 并开始代工侵入型电极。 Neuralink 需定制 ASIC 芯片，因通用芯片无法在处理上千通道信号的 同时控制功耗。其关键部分是模拟前端，需实现微弱神经信号的放大、 滤波和数字化。 Q&A 目前医药板块的投资机会主要集中在哪些方向？ 当前医药板块的投资机会主要集中在创新药及其相关产业链上。尤其是一些龙 头企 ...

鱼羊 发自 凹非寺 量子位 | 公众号 QbitAI 让特斯拉转型成「机器人」公司，马斯克来真的了： 在最新财报电话会议上，马斯克宣布，特斯拉将在2026年第二季度 停产豪华车型Model S和Model X 。 现在是时候让Model S和Model X体面地退出舞台了，因为我们正在迈向一个以自动驾驶为基础的未来。 擎天柱官推则更为明确地放出了这样一个视频，配文： Model S和X将通过我继续存在。 马斯克透露，在把特斯拉加州弗里蒙特工厂的Model S/X生产线改造成擎天柱生产线后，其机器人的产量将达到 每年一百万台 。 特斯拉「情怀」车型走向终结 Model S/X的退役，倒也不是无迹可寻。 毕竟马斯克2019年就说过，这两款分别诞生于2012年和2015年的车型纯粹是因为"情感原因"才被继续生产的。 数据很直接：在过去几年里，特斯拉每年能卖出差不多170万辆车，其中Model S/X也就占几个百分点，并且销量还在持续下降。 目的很明确，就是要给特斯拉机器人擎天柱 （Optimus） 让出生产线。 财报显示，特斯拉第四季度净利润为8.40亿美元，较上年同期下降了61%。 | ($ in million ...

马斯克旗下 脑机接口公司Neuralink周三表示，于正式开始人体测试两年后，公司目前在全球范围内的 临床试验中共有21名参与者，较去年9月的12人有所增加，当时该等参与者已经接受其芯片并用其通过 思维控制数位和实体工具。公司表示，正与监管机构和医院合作，为参与者提供改良的设备，并维持目 前未发生任何严重装置相关不良事件的纪录。 ...

Blindsight is coming"The next Neuralink product is BlindSight which will enable people who have lost both eyes or have no eye sight to see."Elon Musk https://t.co/uv8ExkuGrU ...

"The vast majority of diseases or brain issues, I think are fixable with a Neuralink device."Elon Muskhttps://t.co/FVCBNaQ8KD ...

马斯克发帖称，新一代神经链接 脑机接口增强版的性能将提升至三倍，将于今年晚些时候面市。待监 管部门批准后，Neuralink准备推出首款盲视增强技术，使那些完全失明的人能够以低分辨率视觉方式进 行感知。 ...

Over time, I think Neuralink could enable vision in a higher resolution than with a human eye, and you could also see in different wavelengths.Elon Muskhttps://t.co/q4uGXH5GBfTesla Owners Silicon Valley (@teslaownersSV):BREAKING: Neuralink is prepared to perform its first human Blindsight implant — a major step toward restoring vision for people with total blindness. It will start with low-resolution sight and improve to higher resolution over time, subject to regulatory approval. https://t.co/2Tc1GB9cyP ...

BREAKING: Neuralink is prepared to perform its first human Blindsight implant — a major step toward restoring vision for people with total blindness. It will start with low-resolution sight and improve to higher resolution over time, subject to regulatory approval. https://t.co/2Tc1GB9cyP ...